Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV